COVID-19 Update: Focus on Clinical Trials | Aplastic Anemia & MDS International Foundation Return to top.

COVID-19 Update: Focus on Clinical Trials

Presenter(s): 
Topic(s): 
COVID-19
Presentation Date: 
Tue, 06/23/2020 - 8:00pm (EDT)

Olatoyosi Sobulo Odenike, MD, is Professor of Medicine in the Section of Hematology/Oncology and Director of the Leukemia Program at the University of Chicago as well as Co-Chair of the AAMDSIF Medical Advisory Board. Dr. Odenike is an expert in the care of adults with leukemia, chronic myeloproliferative diseases, and myelodysplastic syndromes. An active researcher, Dr. Odenike is involved in the development of novel therapeutic agents for the treatment of acute and chronic leukemias and chronic myeloproliferative diseases. The ultimate goal of her research is to improve treatment options for patients with these diseases. Dr. Odenike is the principal investigator on a number of clinical trials investigating molecularly targeted agents in this patient population. These clinical trials also integrate laboratory studies to evaluate the effect that these agents have on cancer cells.

Share with addtoany.com.